12

2023

-

01

Hubei Guangchen Pharmaceutical Allopurinol API Transfer A

Author:


On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.

On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.

1

Allopurinol and its metabolites can inhibit xanthine oxidase, prevent hypoxanthine and xanthine from converting to uric acid, thereby reducing the concentration of uric acid in the blood, reducing the deposition of uric acid salts in bones, joints, and kidneys, and can inhibit the production of uric acid synthesis.

Related News

Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.

2024-12-31

The 10th anniversary celebration and phase II production launch ceremony of Hubei Guangchen Pharmaceutical Co., Ltd. was a complete success.

2024-11-28

Yichang City Pharmaceutical and Health Chamber of Commerce warmly celebrates the successful completion of the 10th anniversary and the commissioning ceremony of the second phase project of Hubei Guangchen Pharmaceutical Co., Ltd.

2024-11-22